Navigation Links
Dr. Andrew Scharenberg, M.D., to Serve as Chief Scientific Officer for Cellectis therapeutics
Date:7/11/2011

PARIS, July 11, 2011 /PRNewswire/ -- Cellectis therapeutics, a subsidiary of Cellectis (Alternext: ALCLS) specializing in the development of therapeutic applications in genome engineering, today announced the appointment of Dr. Andrew M. Scharenberg as Chief Scientific Officer.

Dr. Scharenberg is an attending physician in Immunology at Seattle Children's Hospital, and Professor of Pediatrics and Immunology at the University of Washington. His academic laboratory is based at Seattle Children's Research Institute, and is world renowned for its work on the development of genome engineering technologies for innovative therapeutic applications.

Dr. Scharenberg is a principal investigator and codirector of the Northwest Genome Engineering Consortium (NGEC), which is focused on new approaches for treating genetic diseases. In addition, he is a cofounder and member of the Board of Director's of Pregenen Inc., a biotechnology spin-off from the NGEC, and a strategic partner of Cellectis focused on the commercial development of novel genome engineering technologies.

"We are thrilled that Andrew Scharenberg has accepted the post of Chief Scientific Officer of our therapeutic subsidiary," stated Chief Scientific Officer of the Cellectis group Frederic Paques. "His experience and energy will push our research teams to achieve their full potential."

About Cellectis therapeutics

Founded in 2008, Cellectis therapeutics is dedicated to the development of innovative therapeutic approaches that use meganucleases to treat genetic diseases, cancers, and persistent viral infections. Its prospective treatment targets the DNA sequence that causes disease, which may be innate (genetic disease) or acquired (viral infection, cancer). Cellectis therapeutics' aim is to fulfill unmet medical needs, giving patients new hope.

About Cellectis

Cellectis improves life by applying its genome engineering expertise to a b
'/>"/>

SOURCE Cellectis
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Genesis Biopharma Appoints William H. Andrews Ph.D. to Board of Directors
2. Andrew P. Mandell - Mr. Diabetes(R) to Sit On ProtoKinetix Advisory Board
3. Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club
4. BioNeutral Groups CEO, Stephen Browand and Chief Scientist, Dr. Andrew Kielbania to Appear on WVOX 1460 AM In Focus Radio Show Hosted by Dr. Dan Miller
5. Veridiam Appoints Andrew Gale as Chief Executive Officer
6. Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics
7. Algeta Appoints Andrew Kay as President and Chief Executive Officer
8. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
9. Saladax Biomedical, Inc. Announces Appointment of Gregory C. Critchfield, M.D., M.S. as Chairman of the Companys Board of Directors
10. Patrick Hwu, M.D., and Mario Sznol, M.D., Join Genesis Biopharmas Scientific and Medical Advisory Board
11. BioNeutral Elects Stephen Holt, M.D., Ph.D as Vice Chairman and Independent Director of the Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Israel , June 18, 2013 ... Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and finished dosage ... the company has been granted a United States ... US and Europe for the oral ... 8,410,176 B2 is titled Intermediate Compounds and Processes for ...
(Date:6/18/2013)... 2013 This webinar will examine ... and promotion, and review the basic FDA regulations ... to apply these principles through real world case ...     The fundamentals on FDA regulations and guidance related ...     Assessing traditional and newer forms of promotional ...
(Date:6/18/2013)... , June 18, 2013 ... ) has announced the addition of the ... [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & ... & Auto Injectors] & Therapeutics [Diabetes & ... report to their offering.      ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 As ... MeMD, Inc proudly announces the release of their ... and Fitness ". , MeMD's goal was to ... landscape of Health 2.0, Health 3.0 and mHealth.The ... likely transform medical care and the fitness industry ...
Breaking Biology Technology:Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2
... Every year, millions of people contend with lower back ... Cornell University engineers in Ithaca and doctors at the ... created a biologically based spinal implant that could someday ... Bonassar, Ph.D., associate professor of biomedical engineering and mechanical ...
... health condition that can lead to damaged heart tissue ... peripheral arterial disease in limbs, amputation, particularly in diabetic ... novel nanostructure that promotes the growth of new blood ... where increased blood flow is needed to supply oxygen ...
... Flexible, transparent electronics are closer to reality with the ... The lab of Rice chemist James Tour lab has ... panels and LED lighting. The research was reported in ... Flexible, see-through video screens may be the "killer app" ...
Cached Biology Technology:In the battle to relieve back aches, Cornell researchers create bioengineered spinal disc implants 2In the battle to relieve back aches, Cornell researchers create bioengineered spinal disc implants 3Restoring blood flow 2Restoring blood flow 3Dream screens from graphene 2Dream screens from graphene 3
(Date:6/18/2013)... Council, Laboratory of Molecular Biology, has been honored ... Investigator Award. Torrent is being recognized for his ... to predict antimicrobial regions in proteins. Luis Rivas, ... applying this algorithm to interrogate full genomes in ... very appealing results." , Torrent obtained his ...
(Date:6/18/2013)... extract of a yellow-flowered mountain plant long used for ... fruit fly populations by an average of 24 percent, ... Rhodiola rosea , also known as ... study leaders Mahtab Jafari and Sam Schriner. They discovered ... unrelated to dietary restriction and affects different molecular pathways. ...
(Date:6/18/2013)... shows that weight gain and increased head size in the ... IQ at early school age. , The study was led by ... than 13,800 children who were born full-term. , The results, published ... who put on 40% of their birthweight in the first four ... were six years of age, compared with babies who only put ...
Breaking Biology News(10 mins):The American Society for Microbiology honors Marc Torrent 2Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds 2IQ link to baby's weight gain in first month 2
... carrot has been produced to help people absorb more calcium. ... Improvement Center studied the calcium intake of humans who ate ... The research, which was done in collaboration with Baylor College ... help prevent such diseases as osteoporosis. If you ...
... UBC researchers have discovered some of the genetic ... fight off pests and disease, uncovering critical new ... Prof. Joerg Bohlmann says this genetic analysis will ... inherent strength, breeding trees that could in time ...
... 14, 2008) Reporting in the online journal BMC Genetics, ... attempted to count the number of genes that contribute to ... over 6,000 genes about 25 percent of the genome ... describing the discovery of a new obesity gene have become ...
Cached Biology News:Got carrots? Vegetables may have bone to pick as calcium providers 2UBC discovery unlocks tree genetics, gives new hope for pine beetle defense 2Body weight influenced by thousands of genes 2
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds...
UV LAMP 254 NM 8 WATT, 1 EA. Category: Nucleid Acid Detection Systems....
... The SelectFX Alexa Fluor 488 Cytochrome c ... you need to detect cytochrome c in ... c primary antibody and an Alexa ... 488 dye exhibits bright green fluorescence that ...
Biology Products: